Effective gmp-compliant point of care manufacturing of antic…

Emerging


3
Citations
0
Refs
2020
Year
Search Works
Work Details
  • DOI 10.1016/j.jcyt.2020.03.261
  • OpenAlex ID W3028351249
  • Type Article
  • Language EN
  • Published 01 May 2020
  • Volume 22 (5)
  • Pages S133
  • Source Cytotherapy
  • Publisher Elsevier BV
  • FWCI 0.18
  • Countries 1
  • Institutions 4
  • Added 29 May 2020
  • Updated 26 Sep 2026
MENU
0

Effective gmp-compliant point of care manufacturing of anticd19 chimeric antigen receptor t cells for non hodgkin lymphoma patients using the clinimacs prodigy®

Article 2020 EN

3

Citations

0

References

9

Authors

0.18

FWCI

Citations by Year
Last 3 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
9 authors
#AuthorInstitutionsORCID
1 Sarah Kleinsorge-Block University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +2 —
2 J. Payne-Schiavone University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +2 —
3 Kayla Zamborsky University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +2 —
4 T.L. Turney University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +1 —
5 Jane Reese University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +2
6 David N. Wald Case Western Reserve Universit… (US)
7 Folashade Otegbeye University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +1
8 Marcos J. G. De Lima University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +1
9 Paolo Fabrizio Caimi University Hospitals of Clevel… (US) University Hospitals Cleveland… (US) +1

Data: OpenAlex